[Form 4] The Beauty Health Company Insider Trading Activity

Rhea-AI Filing Summary

Form 4 Overview – The Beauty Health Company (SKIN)

Director Desiree Gruber filed a Form 4 reporting the award of 73,051 Class A common-stock RSUs on 16 June 2025. The award was coded “A” (acquired) and represents equity compensation rather than an open-market purchase. After this grant, Gruber’s total beneficial ownership rises to 192,565 shares, all held directly.

Vesting Terms

• The RSUs vest on the earlier of (i) the one-year anniversary of the grant date or (ii) the 2026 annual meeting of shareholders.
• Continuous board service is required through the vesting date.

Key Takeaways for Investors

• The filing signals continued board-level alignment with shareholders, although the grant is part of the regular director compensation program rather than a discretionary purchase.
• No derivative securities transactions were reported, and no shares were disposed of.
• The transaction does not alter the company’s cash position or share count today, but it will have a modest dilutive effect upon vesting.

Positive

• Director equity grant increases insider ownership to 192,565 shares, modestly aligning board and shareholder interests.

Negative

• None.

Insights

Financial Analyst

TL;DR – Routine RSU grant; minor, generally positive alignment signal; limited market impact.

This Form 4 details a standard board compensation grant, adding 73,051 RSUs to Director Desiree Gruber’s holdings. Because it is not an open-market purchase, the signal value is weaker than a cash-funded buy but still indicates commitment to the issuer’s long-term performance. The resulting ownership of 192,565 shares is not large enough to be market-moving for a company of Beauty Health’s size, and the dilutive effect at vesting is immaterial. Overall, the disclosure is routine and should not materially influence valuation or near-term trading dynamics.

Corporate Governance Expert

TL;DR – Standard compensation grant; governance-neutral, investor impact minimal.

The RSU award follows typical director-compensation practices and vests within one year or at the next AGM, aligning director incentives with shareholder interests without imposing onerous service conditions. No red flags regarding accelerated vesting, option repricing, or unusual contract terms are present. Consequently, the filing is governance-compliant and non-impactful from a risk-assessment perspective.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gruber Desiree

(Last) (First) (Middle)

C/O THE BEAUTY HEALTH COMPANY

2165 SPRING STREET

(Street)

LONG BEACH CA 90806

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Beauty Health Co [ SKIN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/16/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	06/16/2025		A(1)		73,051	A(1)	(1)	192,565	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2026 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time.

Remarks:

	/s/ Desiree Gruber	06/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many shares did Director Desiree Gruber receive according to the Form 4 for SKIN?

73,051 restricted stock units were granted on 16 June 2025.

What is the vesting schedule for the newly granted RSUs reported by SKIN?

The RSUs vest on the earlier of the one-year anniversary of the grant or the 2026 annual shareholder meeting, subject to continued board service.

What is Desiree Gruber’s total beneficial ownership in Beauty Health (SKIN) after the transaction?

Following the grant, she beneficially owns 192,565 Class A common shares.

Did the Form 4 for SKIN report any share disposals or sales?

No. The filing only disclosed an acquisition of RSUs; there were no disposals.

Is the reported transaction part of a 10b5-1 trading plan?

The filing does not indicate that the RSU grant was executed under a 10b5-1 plan.